![Dennis Wright](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 1 Mio $ am 31.05.2026
Dennis J.
Wright is currently the Chief Scientific Officer at Clinuvel Pharmaceuticals Ltd. He previously worked as the Manager-Global Pharmacovigilance at Mayne Pharma Ltd. Dr. Wright obtained undergraduate, graduate, and doctorate degrees from The University of Sydney.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.08.2025 | 192’312 ( 0.38% ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
| Unternehmen | Position | Ende |
|---|---|---|
Mayne Pharma Ltd.
 Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
 Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
